Your browser doesn't support javascript.
loading
JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.
Oh, Yunmoon; Lee, Jin-Sol; Lee, Ji Sun; Park, Jae Hyeon; Kim, Hyung Sik; Yoon, Sungpil.
Affiliation
  • Oh Y; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Lee JS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Lee JS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Park JH; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Kim HS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Yoon S; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Int J Mol Sci ; 23(9)2022 Apr 21.
Article in En | MEDLINE | ID: mdl-35562984
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antimitotic Agents / Janus Kinase Inhibitors / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antimitotic Agents / Janus Kinase Inhibitors / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article